What is the current share price of Zota Health Care LImited (ZOTA)?

As of the latest market update, Zota Health Care LImited (ZOTA) is trading at ₹1,225.2. The stock has moved 2.39% up in the recent session.

What is the technical sentiment for ZOTA stock?

Based on our proprietary technical analysis, the current signal for ZOTA is "NEUTRAL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Zota Health Care LImited?

Zota Health Care LImited has seen a 52-week high of ₹1,740 and a 52-week low of ₹917.2. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Zota Health Care LImited belong to?

Zota Health Care LImited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of ZOTA?

Zota Health Care LImited (ZOTA) has a market capitalization of approximately ₹4.14K Cr. This classifies it as a small cap stock in the Indian market.

ZOTA

NSE

Zota Health Care LImited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹1,225.20

28.60 (2.39%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹4.14K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

N/A

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹917.2+33.6%

52W High₹1,740-29.6%

Current Price

₹1,225.20

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹980.16

Upper Circuit₹1,470.24

Reference Price

₹1,225.20

Investment Checklist

Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1123.5

Double Top on 1D (BREAKOUT CONFIRMED) — target ₹1302.2

10/20 Bullish Cross detected 2 day(s) ago

EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.

SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Analysis from 2026-06-12

Confidence

45%

Trend

NEUTRAL

Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)

EMA20

1203.95

EMA50

1218.98

EMA200

1280.57

Price Action

MIXED

NEUTRAL

Higher Highs5

Higher Lows6

Lower Highs4

Lower Lows3

Support & Resistance Levels

Resistance (Above)

₹1228.40

₹1243.90

₹1269.70

₹1302.30

₹1369.42

Support (Below)

₹1177.00

₹1145.71

₹1100.00

₹1071.00

₹1050.00

Volume Analysis

TrendINCREASING

Change+66.60%

Unusual VolumeNo

Recent MA Crossovers

10/20 Bullish Cross

2 days ago

BUY

Stop Loss Levels

Fixed Risk

1% Risk₹1212.95

3% Risk₹1188.44

5% Risk₹1163.94

7% Risk (Custom)

₹1139.44

Technical Levels

1x ATR (Volatility)₹1173.15

2x ATR (Swing)₹1121.10

3x ATR (Trend)₹1069.05

Immediate Support₹1177.00

Moving Averages

EMA 9 (Short-term)₹1204.63

EMA 20 (Medium-term)₹1203.95

EMA 50 (Trend)₹1218.98

Financials

Financial Analysis

Metric	Sep '24	Dec '24	Mar '25	Jun '25
Revenue	₹67.3 Cr	₹72.1 Cr	₹97.3 Cr	₹103.6 Cr
Net Profit	₹-12.1 Cr	₹-18.7 Cr	₹-12.9 Cr	₹-14.3 Cr
EPS	₹-4.57	₹-6.80	—	₹-4.92
Operating Profit	₹-32,74,000	₹-5.6 Cr	₹1.7 Cr	₹4.8 Cr

ROE

-25.21%

ROCE

-13.40%

Debt/Equity

0.62

Current Ratio

1.83

OPM

4.66%

NPM

-13.82%

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
22 Sept 2025	Dividend - Re 1 Per Share	DIVIDEND
20 Sept 2024	Annual General Meeting/Dividend - Re 1 Per Share	AGM
22 Sept 2023	Annual General Meeting/Dividend - Re 1 Per Share	AGM
19 Sept 2022	Annual General Meeting/Dividend - Rs 1.50 Per Share	AGM
22 Sept 2021	Annual General Meeting/ Dividend Rs 1 Per Share	AGM

Announcements

Latest updates

View All

Date	Description	Link
05 Jun 2026	Analysts/Institutional Investor Meet/Con. Call Updates
05 Jun 2026	Disclosure under SEBI Takeover Regulations
29 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
22 May 2026	Financial Results/Dividend/Other business matters
22 May 2026	Board Meeting Intimation	XBRL
04 Feb 2026	Board Meeting Intimation	XBRL
04 Feb 2026	Financial Results/Other business matters
17 Oct 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025Pledged: 0.26%

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ZOTA

View All

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

positive

ET Markets - Industry 4d ago

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.

AGARWALEYEAMRUTANJANGLOBALGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsConsumer Services

Read full story

NEWS

positive

Business Standard - Markets 5d ago

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Read full story

NEWS

positive

Business Standard - Markets 5d ago

Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife

Viyash Scientific rose 1.59% to Rs 259.20 after the company's wholly owned subsidiary, Alivira Animal Health, has inked a binding agreement to acquire a 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Read full story

ZOTA

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ZOTA

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife

Frequently Asked Questions

What is the current share price of Zota Health Care LImited (ZOTA)?

What is the technical sentiment for ZOTA stock?

What is the 52-week high and low for Zota Health Care LImited?

Which sector does Zota Health Care LImited belong to?

What is the market capitalization of ZOTA?